2009 State of the Industry: Prince Edward IslandMoving forward BC docs set to work with pharmacists Piroxicam: indications restricted Piroxicam is no longer indicated for the treatment of acute pain or inflammation. SPA more painful, less effective than urinary catheterization Seeking drug plan 'Solutions' Finding ways to manage chronic disease in the workplace is a growing issue for sponsors of employee drug plans concerned about ongoing cost increases. Simponi: new biologic for RA, psoriatic arthritis and ankylosing spondylitis Schering-Plough is introducing Simponi (golimumab), a new tumour necrosis factor (TNF) alpha inhibitor. A new approach to heart attacks Quick angioplasty improves outcomes - study CIHI reports on joint replacement Study looks at age, sex and body mass Guidelines overturn 'automatic' C-sections SOGC advice for breech presentations Lyme disease: exposure risk increasing New evidence suggests that the risk of exposure to Lyme disease in eastern and central Canada in increasing. First Previous 2285 2286 2287 2288 2289 Next Last
